Inogen (INGN) Misses Q1 EPS by 18c

Inogen (NASDAQ: INGN) reported Q1 EPS of ($0.88), $0.18 worse than the analyst estimate of ($0.70). Revenue for the quarter came in at $72.2 million versus the consensus estimate of $76.31 million.

For earnings history and earnings-related data on Inogen (INGN) click here.

You May Also Be Interested In

• AI and earnings keep driving markets as focus shifts to Trump-Xi summit
• AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c
• UBS Reiterates Buy Rating on Option Care Health (OPCH) Following Check-in Call Ahead of Quiet Period